Join us for the fourth offering in our De-Risking Biotech Series, including a networking opportunity!
About this event
Can the choice of corporate structure make a difference in achieving your start up goals?
On Dec. 7th, hear from unconventional founders Jen Horonjeff, CEO public employee benefits cooperative Savvy Cooperative, & Ethan Perlstein, CEO public benefit corporation Perlara, as they share their insights on building a successful bio company through thoughtful use of structure.
We dive into how corporate structure relates to your mission, customers, staff, & funds. Immediately following the Q&A portion of the panel, you'll have an opportunity to meet & talk with our speakers at virtual tables. Get to know more about them below!
Ethan Perlstein, PhD., Founder & CEO, Perlara
Dr Ethan Perlstein is the founder & CEO of Perlara PBC, the first biotech public benefit corporation that develops treatments & cures for genetic diseases in partnership with entrepreneurial families & foundations. Ethan is also a founder & CEO of Maggie's Pearl, a joint venture co-owned by Perlara & a pioneer family that is commercializing the aldose reductase inhibitor epalrestat for the most common congenital disorder of glycosylation (PMM2-CDG). Ethan was a Lewis-Sigler Fellow at Princeton & received his doctorate in molecular & cell biology from Harvard University.
Jen Horonjeff, CEO, Savvy Cooperative, ELabNYC Alumni '18
Jen Horonjeff, PhD, is a patient advocate & the founder & CEO of Savvy Cooperative, the first & only patient-owned co-op that helps innovators connect directly with diverse patients in order to get the insights they need to build better & more inclusive healthcare solutions. Jen was named one of the 50 Most Daring Entrepreneurs of 2018 by Entrepreneur Magazine for her work at Savvy. She was participating in the ELabNYC program during that exciting time. She grew up with multiple autoimmune conditions & survived a brain tumor as an adult, & is also a patient-centered outcomes researcher, a human factors engineer, & formerly an FDA advisor. Jen strives to give patients a platform to have their experiences be heard, included, & equitably valued.
About Accelerator for Biosciences in CT:
ABCT's program of education & business networking prepares Connecticut's academic & corporate spinouts, inventors & first time founders to be successful entrepreneurs.
BioLabs New York is partnering with NYU Langone Health to build a unique biotech co-working facility in Manhattan to attract the best companies in early-stage life sciences.
BioLabs@NYULangone provides an engaging, collaborative space, top-of-the-line research equipment, business support & acceleration programming to help startup companies reach their milestones faster.
About Westchester County Biosciences Accelerator:
WCBA's goal is to support the development of Westchester's hub of bioscience innovation & commercialization with a program of emerging venture education & business networking.
De-risking Early Stage Biotech is a series co-produced by Biolabs@NYULangone & Design Technologies. The seminars & discussions are designed to shed light & focus on specific hurdles addressing the perspective of founders, investors, regulators, & industry stakeholders.